Filtered By:
Specialty: Cardiology
Condition: Diabetes Type 2
This page shows you your search results in order of relevance. This is page number 3.
Order by Relevance | Date
Total 574 results found since Jan 2013.
Knowledge of stroke risk factors and warning symptoms among adults with type 2 diabetes in Addis Ababa, Ethiopia, 2021: an institution-Based cross-sectional study
Stroke is a global public health concern with type 2 diabetes being one of the common risk factors. Knowledge of stroke risk factors and warning symptoms among type 2 diabetes patients is largely unknown in de...
Source: BMC Cardiovascular Disorders - January 16, 2023 Category: Cardiology Authors: Rediet Akele Getu, Fekadu Aga, Tadesse Badada, Sewnet Getaye Workie, Makda Abate Belew and Kalkidan MekonnenRN Tags: Research Source Type: research
Type 2 diabetes mellitus, atherosclerosis, and ischemic stroke: Histopathological changes of the brain
Background and Aims: Type 2 diabetes mellitus is associated with a marked increase in the risk of atherosclerotic diseases, including cerebrovascular disease. Atherosclerosis and ischemic stroke in diabetic patients occur 4 times more often than in the general population. Our aim was to investigate the brain tissue of patients with type 2 diabetes mellitus who died from ischemic stroke.
Source: Atherosclerosis - August 1, 2023 Category: Cardiology Authors: L. Volos, T. Mykhaylichenko Source Type: research
Special Diet Quells Genetic Risk of Stroke (CME/CE)
(MedPage Today) -- The Mediterranean diet may lower the risk of stroke in patients with a certain genetic variant that makes them susceptible to type 2 diabetes and metabolic troubles, researchers found.
Source: MedPage Today Cardiovascular - August 13, 2013 Category: Cardiology Source Type: news
Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis
To analyze whether medical care is in accordance with guidelines for secondary prevention of myocardial infarction (MI), or stroke in patients with type 2 diabetes from Germany and Austria.
Source: Cardiovascular Diabetology - May 3, 2016 Category: Cardiology Authors: Barbara Bohn, Christof Schöfl, Vincent Zimmer, Michael Hummel, Nikolai Heise, Erhard Siegel, Wolfram Karges, Michaela Riedl and Reinhard W. Holl Source Type: research
Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
CONCLUSIONS: The prevalence of ASCVD is higher, and the involvement of the arterial territories is different in FH patients when compared with their unaffected relatives. Age, male sex, increased body mass index, hypertension, type 2 diabetes mellitus, smoking habit, and lipoprotein(a) >50 mg/dL were independently associated to ASCVD.
CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02693548.
PMID: 27444203 [PubMed - as supplied by publisher]
Source: Arteriosclerosis, Thrombosis and Vascular Biology - July 20, 2016 Category: Cardiology Authors: Pérez de Isla L, Alonso R, Mata N, Saltijeral A, Muñiz O, Rubio-Marin P, Diaz-Diaz JL, Fuentes F, de Andrés R, Zambón D, Galiana J, Piedecausa M, Aguado R, Mosquera D, Vidal JI, Ruiz E, Manjón L, Mauri M, Padró T, Miramontes JP, Mata P, SAFEHEART In Tags: Arterioscler Thromb Vasc Biol Source Type: research
Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study Health Services and Outcomes Research
BackgroundStatin therapy is a cornerstone of cardiovascular disease risk reduction for people with diabetes mellitus. Past reports have shown race‐sex differences in statin use in general populations, but statin patterns by race and sex in those with diabetes mellitus have not been thoroughly studied.Methods and ResultsOur sample of 4288 adults ≥45 years of age with diagnosed diabetes mellitus who had low‐density lipoprotein cholesterol (LDL‐C)>100 mg/dL or were taking statins recruited for the Reasons for Geographic and Racial Differences in Stroke study from 2003 to 2007. Exposures included race‐sex groups (w...
Source: JAHA:Journal of the American Heart Association - May 10, 2017 Category: Cardiology Authors: Gamboa, C. M., Colantonio, L. D., Brown, T. M., Carson, A. P., Safford, M. M. Tags: Lipids and Cholesterol, Diabetes, Type 2, Epidemiology, Race and Ethnicity, Health Services Original Research Source Type: research
The effect of the presence and the level of dyslipidemia control on diabetic patients with first acute ischemic stroke
Aim: Study of the effect of the presence and the level of dyslipidemia control on patients with type 2 diabetes mellitus (T2DM) and a first acute ischemic stroke (AIS).
Source: Atherosclerosis - August 1, 2017 Category: Cardiology Authors: Ioannis Kyriazis, Konstantinos Sgouros, Dimitra Stefani, Kalliopi Vallianou, Panagiotis Georgakopoulos, Ioannis Tsamis, Sophia Petropoulou, Ioannis Kachrimanidis, Kosntantina Kyre, Athanasios Drosos, Moyssis Lelekis Source Type: research
Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
The cardiovascular safety and efficacy of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus (T2DM) after acute coronary syndrome (ACS) or acute ischemic stroke (AIS) ar...
Source: Cardiovascular Diabetology - January 4, 2018 Category: Cardiology Authors: Yan-Rong Li, Sung-Sheng Tsai, Dong-Yi Chen, Szu-Tah Chen, Jui-Hung Sun, Hung-Yu Chang, Miaw-Jene Liou and Tien-Hsing Chen Tags: Original investigation Source Type: research
PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Status and Protection Against Ischemic Stroke: PheWAS, TreWAS, and More Editorial
Source: Circulation: Cardiovascular Genetics - July 11, 2018 Category: Cardiology Authors: Sullivan, D., Bonnitcha, P., Spinks, C., Keech, T. Tags: Cardiovascular Disease, Diabetes, Type 2, Genetic, Association Studies, Ischemic Stroke Editorial Source Type: research
Pioglitazone and PPAR- γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study
Peroxisome proliferator-activated receptor- γ (PPAR-γ) modulating treatment may have cardiovascular benefits in type 2 diabetes mellitus (T2DM) patients after ischemic stroke (IS). However, whether there are ad...
Source: Cardiovascular Diabetology - January 7, 2020 Category: Cardiology Authors: Chi-Hung Liu, Tsong-Hai Lee, Yu-Sheng Lin, Pi-Shan Sung, Yi-Chia Wei and Yan-Rong Li Tags: Original investigation Source Type: research
Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study
Studies assessing the efficacy of pioglitazone solely for primary stroke prevention in Asian patients with type 2 diabetes mellitus (DM) and present multiple cardiovascular (CV) risk factors are rare. Thus, we...
Source: Cardiovascular Diabetology - June 20, 2020 Category: Cardiology Authors: Yi-Chih Hung, Lu-Ting Chiu, Hung-Yu Huang and Da-Tian Bau Tags: Original investigation Source Type: research
Association of ACE2 variant rs4646188 with the risks of atrial fibrillation and cardioembolic stroke in Uygur patients with type 2 diabetes
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Type 2 diabetes (T2D) is an independent risk factor for AF. The cardioembolic stroke (CS) risk is increased when both conditions coexist. Whether...
Source: BMC Cardiovascular Disorders - February 18, 2021 Category: Cardiology Authors: Cheng Liu, Jingxian Pei, Yanxian Lai, Tianwang Guan, Abudurexiti Zeyaweiding, Tutiguli Maimaiti, Haiyan Zhao and Yan Shen Tags: Research article Source Type: research
B-po05-144 comparing sodium glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset atrial fibrillation and ischemic stroke
Given the susceptibility of patients with type 2 diabetes mellitus towards cerebrovascular complications, there is increasing research on the cerebrovascular-protective effects of novel anti-diabetic agents. However, few studies have compared sodium glucose cotransporter-2 inhibitor (SGLT2I) and dipeptidyl peptidase-4 inhibitor (DPP4I) in their effects on stroke and atrial fibrillation (AF).
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Sharen Lee, Jiandong Zhou, Xiansong Wang, Carlin Chang, Tong Liu, Dong Chang, Wing Tak Wong, William K.K. Wu, Bernard M.Y. Cheung, Gary Tse, Qingpeng Zhang Source Type: research
Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke
Post-stroke functional recovery is severely impaired by type 2 diabetes (T2D). This is an important clinical problem since T2D is one of the most common diseases. Because weight loss-based strategies have been...
Source: Cardiovascular Diabetology - December 22, 2021 Category: Cardiology Authors: Dimitra Karampatsi, Alexander Zabala, Ulrika Wilhelmsson, Doortje Dekens, Ellen Vercalsteren, Martin Larsson, Thomas Nystr öm, Milos Pekny, Cesare Patrone and Vladimer Darsalia Tags: Original investigation Source Type: research
GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?
In Kim and colleagues' article [1] reporting a retrospective cohort study aiming to assess the cardiorenal benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) versus glucagon-like peptide-1 receptor agonists (GLP1RA) in patients with type 2 diabetes mellitus (T2DM), one main conclusion is that GLP1RA tended to have more favorable ischemic outcomes. To some extent, this conclusion is exaggerated because GLP1RA and SGLT2i had the similar risks of coronary revascularization and stroke according to the main results of this article.
Source: International Journal of Cardiology - July 12, 2022 Category: Cardiology Authors: Lixin Du, Yu Zhang, Pan Wang, Zhigang Li, Yunhui Zhao, Jianpeng Yuan Tags: Letter to the Editor Source Type: research
